Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Palantir (PLTR) stock is tumbling 11% after its CEO implemented a new stock-trading plan and a report stated that the ...

Palantir Technologies received a new Buy rating from Loop Capital and continued bullish support from Wedbush on Thursday, despite recent market concerns over potential U.S. defense budget cuts.

U.S. defense stocks opened in the red on Thursday, Feb. 20 following reports that President Donald Trump’s administration has ...

In today’s CEO Daily: Diane Brady with President Trump at FII in Miami. The big story: Trump v the World. The markets: ...

Key Takeaways Palantir shares tumbled Thursday on expectations of defense spending cuts; this week's losses put the stock in ...

On Wednesday morning, Wingstop said revenue rose 27%, to $161.8 million. Revenue was below Wall Street forecasts, while earnings were higher than analysts expected, according to FactSet. Wingstop ...

One analyst thinks Palantir will end up benefiting from Pentagon budget cuts, contrary to fears. But the stock remains pricey ...

Palantir shares continued to decline on Thursday, extending a sharp sell-off. The stock fell nearly 9%, following Wednesday’s ...

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here’s ...